2880-96-8

Basic information

• Product Name: methyl 2,3-anhydro-4,6-oxy-benzylidene-β-D-mannopyranoside
• Synonyms: methyl 2,3-anhydro-4,6-oxy-benzylidene-β-D-mannopyranoside
• CAS NO: 2880-96-8
• Molecular Weight: 264.278
• Mol File: 2880-96-8.mol
• Article Data: 30

Chemical Properties

• CAS DataBase Reference: methyl 2,3-anhydro-4,6-oxy-benzylidene-β-D-mannopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2,3-anhydro-4,6-oxy-benzylidene-β-D-mannopyranoside(2880-96-8)
• EPA Substance Registry System: methyl 2,3-anhydro-4,6-oxy-benzylidene-β-D-mannopyranoside(2880-96-8)

Safety Data

• Hazardous Substances Data: 2880-96-8(Hazardous Substances Data)

Upstream product

• 120200-47-7 methyl-[O³-benzoyl-O⁴,O⁶-((R)-benzylidene)-O²-(toluene-4-sulfonyl)-α-D-glucopyranoside] 
• 67-56-1 methanol 
• 124-41-4 sodium methylate 
• 99265-93-7 methyl-[O⁴,O⁶-((R)-benzylidene)-O²,O³-bis-(toluene-4-sulfonyl)-α-D-altropyranoside] 
• 3053-12-1 methyl-[O³-acetyl-O⁴,O⁶-((R)-benzylidene)-O²-(toluene-4-sulfonyl)-α-D-glucopyranoside] 
• 70774-92-4 methyl 4,6-O-benzylidene-2-O-p-toluenesulphonyl-α-D-glucopyranoside 
• 28538-15-0 methyl-[O²-benzoyl-O⁴,O⁶-((R)-benzylidene)-O³-methanesulfonyl-α-D-altropyranoside] 
• 3162-96-7 4,6-O-benzylidene-1-O-methyl-α-D-glucopyranoside 
• 71117-41-4 methyl 4,6-O-benzylidene-α-D-altropyranoside 
• 6748-92-1 methyl-[O³-benzoyl-O⁴,O⁶-((S)-benzylidene)-O²-(toluene-4-sulfonyl)-α-D-galactopyranoside] 
• 86420-67-9 methyl 4,6-O-benzylidene-α-D-galactopyranoside 2-O-p-toluenesulfonate 
• 86420-66-8 methyl 4,6-O-benzylidene-α-D-galactopyranoside 2,3-di-O-p-toluenesulfonate 
• 71-43-2 benzene 
• 64552-06-3 methyl 4,6-O-benzylidene-α-D-galactopyranoside 

Downstream Products

• 497180-22-0 methyl-[O⁴,O⁶-((R)-benzylidene)-3-iodo-3-deoxy-α-D-altropyranoside] 
• 626200-80-4 methyl 4,6-O-benzylidene-3-deoxy-3-C-ethyl-α-D-altropyranoside 
• 65530-27-0 (2R,4aR,6S,8aS)-(+)-6-methoxy-2-phenyl-4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxine 
• 71184-15-1 methyl-3-deoxyamino-4,6-dioxabenzylidene-α-D-altropyranose 
• 6198-74-9 methyl (R)-3-deoxy-α-D-arabinohexopyranose 
• 72904-78-0 methyl 3-deoxy-4,6-O-phenylmethylene-α-D-arabinohexopyranoside 
• 71117-41-4 methyl 4,6-O-benzylidene-α-D-altropyranoside 
• 30571-48-3 methyl-[O⁴,O⁶-((R)-benzylidene)-3-bromo-3-deoxy-α-D-altropyranoside] 
• 74410-53-0 Methyl 4,6-O-benzylidene-3-O-methyl-α-D-altropyranoside 
• 74560-56-8 methyl 4,6-O-(S)-benzylidene-α-D-idopyranoside 
• 74560-63-7 methyl 4,6-O-(S)-benzylidene-3-methyl-α-D-idopyranoside 
• 2484-81-3 methyl-[O²-acetyl-3-acetylamino-O⁴,O⁶-((S)-benzylidene)-3-deoxy-α-D-idopyranoside] 
• 287191-51-9 methyl 4,6-O-benzylidene-β-D-idopyranoside 
• 6752-76-7 methyl 4,6-O-benzylidene-2-O-methyl-β-D-idopyranoside 

Relevant articles and documents

A Domino Epoxide Ring-Opening Xanthate Migration Reaction: An Alternative Entry to Thiosugars

A sterereospecific and efficient synthesis of thiosugars derived from levoglucosenone and methyl α-d-glucopyranoside was developed by a domino epoxide ring opening- xanthate migration to afford 1,3-oxathiolane-2-thiones in high yields. The stereochemical outcome of the new C–S bond was defined by the configuration of the starting materials. The 1,3-oxathiolane-2-thiones were subsequently submitted to a second tandem reaction affording the corresponding 2,3-episulfide alcohols. The thiosugars obtained are useful building blocks for the synthesis of thiooligosaccharides with potential biological properties.

SUGAR-LINKER-DRUG CONJUGATES

The present disclosure relates to sugar-linker-drug conjugates, of the formula [A-B-]n-L-D, wherein A is a saccharide; B is a spacer, n is an integer selected from 1 to 3; L is a linker group and D is a drug having a chemically reactive functional group selected from the group consisting of a primary or secondary amine, hydroxyl, sulfhydryl, carboxyl, aldehyde and ketone. Pharmaceutical compositions comprising the conjugates and methods of using thern are also provided.

AN EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM

The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.